Eric Kmiec named editor in chief of Gene and Genome Editing

Eric Green leaves his job as director of the NIH National Human Genome Research Institute

After serving as the director of the National Human Genome Research Institute for more than 15 years, Eric Green has left his role.

March 21, 2025

Vol.51 No.11

Clinical Trials & Tribulations

The new therapeutic imperative in cancer management: Sequence, biosimulate, treat

The definition of “therapeutic imperative” is this: A treatment necessity that must be met in order to prevent death. Once the imperative is clearly defined, addressing it properly links correct diagnosis with therapy and favorable prognosis. On the other hand, misdiagnosis or inadequate diagnosis fails to provide a framework for highly effective or curative therapy.

Researchers identify HMGA1 as key driver in colon cancer development

A gene called high mobility group A1 may be the key that opens the door to the development of colon cancer, according to research led by investigators from the Johns Hopkins Kimmel Cancer Center, Johns Hopkins Department of Medicine, Johns Hopkins Department of Pathology and the Johns Hopkins Institute for Cell Engineering.

February 28, 2025

Vol.51 No.08

Obituary

Felix Feng, GU cancer researcher who made fundamental discoveries in genomics, dies at 48

The University of California, San Francisco and global oncology communities mourn the death of Felix Y. Feng, MD, a radiation oncologist and a leading figure in genitourinary cancer research. A professor of radiation oncology, urology and medicine, and vice chair of translational research at the UCSF Helen Diller Family Comprehensive Cancer Center, Feng died from cancer on Dec.10, 2024. He was 48.

Felix Feng: “When a symposium is named after you, you can pretty much just wax poetic up on stage.”
Keynote address at The Feng Symposium in May 2024

On May 18, 2024, Felix Feng, a leader in genitourinary cancer research, gave the keynote address at the inaugural symposium that bears his name.

January 24, 2025

Vol.51 No.03

Clinical Roundup

Deadly dog cancer reveals clues for improved treatment, UF study finds

Researchers at the University of Florida College of Veterinary Medicine and the UF Health Cancer Center have identified a crucial link between a gene mutation and immune system signaling in canine hemangiosarcoma, a discovery that could lead to better treatments for both dogs and humans with similar cancers.

January 24, 2025

Vol.51 No.03

Eric Kmiec named editor in chief of Gene and Genome Editing

YOU MAY BE INTERESTED IN

Eric Green leaves his job as director of the NIH National Human Genome Research Institute

The new therapeutic imperative in cancer management: Sequence, biosimulate, treat

Researchers identify HMGA1 as key driver in colon cancer development

Felix Feng, GU cancer researcher who made fundamental discoveries in genomics, dies at 48

Felix Feng: “When a symposium is named after you, you can pretty much just wax poetic up on stage.”
Keynote address at The Feng Symposium in May 2024

Deadly dog cancer reveals clues for improved treatment, UF study finds

Renew today!

Subscriber content

Never miss an issue!

Login

Eric Kmiec named editor in chief of Gene and Genome Editing

YOU MAY BE INTERESTED IN

Eric Green leaves his job as director of the NIH National Human Genome Research Institute

The new therapeutic imperative in cancer management: Sequence, biosimulate, treat

Researchers identify HMGA1 as key driver in colon cancer development

Felix Feng, GU cancer researcher who made fundamental discoveries in genomics, dies at 48

Felix Feng: “When a symposium is named after you, you can pretty much just wax poetic up on stage.”Keynote address at The Feng Symposium in May 2024

Deadly dog cancer reveals clues for improved treatment, UF study finds

Never miss an issue!

Login

Felix Feng: “When a symposium is named after you, you can pretty much just wax poetic up on stage.”
Keynote address at The Feng Symposium in May 2024